SG11202105690TA - Ire1 small molecule inhibitors - Google Patents

Ire1 small molecule inhibitors

Info

Publication number
SG11202105690TA
SG11202105690TA SG11202105690TA SG11202105690TA SG11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA
Authority
SG
Singapore
Prior art keywords
small molecule
molecule inhibitors
ire1
ire1 small
inhibitors
Prior art date
Application number
SG11202105690TA
Other languages
English (en)
Inventor
Joseph P Vacca
Sarah Bettigole
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of SG11202105690TA publication Critical patent/SG11202105690TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11202105690TA 2018-12-03 2019-12-02 Ire1 small molecule inhibitors SG11202105690TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862774794P 2018-12-03 2018-12-03
PCT/US2019/063921 WO2020117635A1 (en) 2018-12-03 2019-12-02 Ire1 small molecule inhibitors

Publications (1)

Publication Number Publication Date
SG11202105690TA true SG11202105690TA (en) 2021-06-29

Family

ID=69024615

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105690TA SG11202105690TA (en) 2018-12-03 2019-12-02 Ire1 small molecule inhibitors

Country Status (8)

Country Link
US (1) US12071426B2 (enExample)
EP (1) EP3891137B1 (enExample)
JP (1) JP7546299B2 (enExample)
AU (1) AU2019393754A1 (enExample)
CA (1) CA3121755A1 (enExample)
IL (1) IL283433A (enExample)
SG (1) SG11202105690TA (enExample)
WO (1) WO2020117635A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI831829B (zh) 2018-09-12 2024-02-11 美商建南德克公司 苯氧基-吡啶基-嘧啶化合物及使用方法
SG11202105690TA (en) 2018-12-03 2021-06-29 Univ Cornell Ire1 small molecule inhibitors
EP3941919B1 (en) 2019-01-03 2025-12-24 Genentech, Inc. Pyrido-pyrimidinone and pteridinone compounds as inhibitors of endoribonuclease inositol requiring enzyme i (ire i alpha) for the treatment of cancer diseases.
CN113795307A (zh) * 2019-02-18 2021-12-14 基因泰克公司 吡啶并嘧啶基化合物及其使用方法
WO2020232403A1 (en) * 2019-05-15 2020-11-19 Cornell University Treatment of fibrosis with ire1 small molecule inhibitors
EP3983400B1 (en) * 2019-06-11 2025-05-28 Genentech, Inc. Quinazolinyl compounds and methods of use
US11840523B2 (en) * 2020-11-13 2023-12-12 The Regents Of The University Of California IRE1α inhibitors and uses thereof
AU2021381949A1 (en) 2020-11-18 2023-06-15 Deciphera Pharmaceuticals, Llc Gcn2 and perk kinase inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8664230B2 (en) * 2011-03-17 2014-03-04 The Asan Foundation Pyridopyrimidine derivatives and use thereof
WO2018102751A1 (en) * 2016-12-02 2018-06-07 Quentis Therapeutics, Inc. Ire1 small molecule inhibitors
CN108239074B (zh) 2016-12-26 2021-07-06 中国医学科学院药物研究所 喹唑啉类化合物及其制备方法、用途和药物组合物
TW201838981A (zh) * 2017-03-17 2018-11-01 美商建南德克公司 嘧啶基-吡啶氧基-萘基化合物以及治療ire1相關之疾病及病症的方法
US20180346446A1 (en) 2017-06-01 2018-12-06 Quentis Therapeutics, Inc. Ire1 small molecule inhibitors
CN111566089B (zh) 2017-11-10 2023-11-17 康奈尔大学 Ire1小分子抑制剂
SG11202105690TA (en) 2018-12-03 2021-06-29 Univ Cornell Ire1 small molecule inhibitors

Also Published As

Publication number Publication date
EP3891137A1 (en) 2021-10-13
AU2019393754A1 (en) 2021-07-22
US20220356168A1 (en) 2022-11-10
WO2020117635A1 (en) 2020-06-11
US12071426B2 (en) 2024-08-27
IL283433A (en) 2021-07-29
JP2022511477A (ja) 2022-01-31
EP3891137B1 (en) 2024-10-09
JP7546299B2 (ja) 2024-09-06
CA3121755A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
IL283639A (en) Kif18a inhibitors
MA54550A (fr) Inhibiteurs de kif18a
EP4007752C0 (en) Kif18a inhibitors
EP3843714C0 (en) CD73 INHIBITORS
IL283433A (en) Small molecule inhibitors of ire1
EP4007753C0 (en) Kif18a inhibitors
MA52413A (fr) Inhibiteurs de cd73
IL269196A (en) Novel inhibitors
EP3548476A4 (en) SMALL MOLECULAR IRE1 INHIBITORS
EP3788042A4 (en) BCL-2 INHIBITORS
IL304348A (en) Cd73 inhibitors
EP3801503A4 (en) INHIBITORS OF SARM1
IL261557A (en) Small molecule ire1-alpha inhibitors
DK3571192T3 (da) Jak1-selektive inhibitorer
MA52813A (fr) Inhibiteurs de sarm1
MA52809A (fr) Inhibiteurs de sarm1
EP3817736A4 (en) PIKFYVE INHIBITORS
EP3773537A4 (en) STAT3 INHIBITORS
EP3980011A4 (en) INHIBITORS OF SARM1
DK3630744T3 (da) Pyrazol-magl-inhibitorer
MA50906A (fr) Inhibiteurs d'immunoprotéasome
IL281514A (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
IL281949A (en) Small molecule menin inhibitors
EP3765619A4 (en) INHIBITORS OF MICRO-RNA 22
EP3600301A4 (en) KDM4 INHIBITORS